I was just looking at some pending patents while doing a search for something on another stock I own (SCLN) and came across this pending patent. http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=36&p=1&f=G&l=50&d=PG01&S1=zadaxin&OS=zadaxin&RS=zadaxinLook at . My point in posting this is that ARQ-501 was once looked at for HIV and now is in trials for cancer. Crazy as it sounds, I wonder if Gemcitabine could be combined with ARQ-501 for the treatment of HCV...as is being done with cancer.MH, any thoughts if this could work?Steve
Steve, I see no basis.